Scientists are claiming significant success in targeting a specific type of blood cancer with engineered immune cells in their first clinical trials.
Subscribe to Guardian Science and Tech ► http://bit.ly/substech
Among several dozen patients who would typically have only had months to live, early experimental trials that used the immune system’s T-cells to target cancers had ‘extraordinary results’. However, the availability of the treatment is still years away.

The Guardian on YouTube:

The Guardian ► http://is.gd/guardianyt
Guardian Football ► http://is.gd/guardianfootball
Guardian Music ► http://is.gd/guardianYTmusic
Guardian Australia ► http://is.gd/guardianaustralia
Guardian Culture ► http://is.gd/guardianculture
Guardian Wires ► http://is.gd/guardianwires
Guardian Food ► http://is.gd/guardianfood
Watch Me Date ► http://is.gd/watchmedate
Video Rating: / 5

Email This Post Email This Post